{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T08:32:37Z","timestamp":1787819557726,"version":"build-2784847793"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["114-S0012"],"award-info":[{"award-number":["114-S0012"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["113-S0097"],"award-info":[{"award-number":["113-S0097"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005866","name":"Far Eastern Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["113\\u20132314-B-002 \\u2212126 -MY3"],"award-info":[{"award-number":["113\\u20132314-B-002 \\u2212126 -MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["114\\u20132314-B-002 \\u2212217 -MY3"],"award-info":[{"award-number":["114\\u20132314-B-002 \\u2212217 -MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006477","name":"National Taiwan University","doi-asserted-by":"publisher","award":["112-FTN0012"],"award-info":[{"award-number":["112-FTN0012"]}],"id":[{"id":"10.13039\/501100006477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006477","name":"National Taiwan University","doi-asserted-by":"publisher","award":["114-FTN0006"],"award-info":[{"award-number":["114-FTN0006"]}],"id":[{"id":"10.13039\/501100006477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006477","name":"National Taiwan University","doi-asserted-by":"publisher","award":["113-FTN0010"],"award-info":[{"award-number":["113-FTN0010"]}],"id":[{"id":"10.13039\/501100006477","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jgar.2026.04.013","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:01:06Z","timestamp":1776283266000},"page":"94-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Comparative in vitro activity of minocycline, tigecycline, eravacycline, and omadacycline against Acinetobacter baumannii, Stenotrophomonas maltophilia, and the Burkholderia cepacia complex"],"prefix":"10.1016","volume":"49","author":[{"given":"Jia-Ling","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5925-2064","authenticated-orcid":false,"given":"Chia-Jui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chung","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann-Tay","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-Huei","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Chwen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2026.04.013_bib0001","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S1473-3099(25)00118-5","article-title":"The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance","volume":"25","author":"Sati","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2026.04.013_bib0002","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/CMR.00019-11","article-title":"Stenotrophomonas maltophilia: an emerging global opportunistic pathogen","volume":"25","author":"Brooke","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2026.04.013_bib0003","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00139-19","article-title":"Burkholderia cepacia complex bacteria: a feared contamination risk in water-based pharmaceutical products","volume":"33","author":"Tavares","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2026.04.013_bib0004","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.drup.2016.07.003","article-title":"Antibiotic resistance in Burkholderia species","volume":"28","author":"Rhodes","year":"2016","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.jgar.2026.04.013_bib0005","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1128\/AAC.00984-16","article-title":"Clinical features and risk factors for development of breakthrough gram-negative bacteremia during carbapenem therapy","volume":"60","author":"Lee","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.04.013_bib0006","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","volume":"7","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.jgar.2026.04.013_bib0007","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1093\/cid\/ciad094","article-title":"Navigating available treatment options for carbapenem-resistant Acinetobacter baumannii-calcoaceticus Complex infections","volume":"76","author":"Shields","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2026.04.013_bib0008","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00345-17","article-title":"Population pharmacokinetics of tigecycline in critically ill patients with severe infections","volume":"61","author":"Xie","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.04.013_bib0009","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3109\/23744235.2015.1064542","article-title":"A Monte Carlo pharmacokinetic\/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia","volume":"47","author":"Wei","year":"2015","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.jgar.2026.04.013_bib0010","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/cid\/ciab1013","article-title":"Infectious Diseases Society of America guidance on the treatment of AmpC beta-lactamase-producing enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections","volume":"74","author":"Tamma","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2026.04.013_bib0011","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00479-22","article-title":"Clinical outcomes of eravacycline in patients treated predominately for carbapenem-resistant Acinetobacter baumannii","volume":"10","author":"Alosaimy","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jgar.2026.04.013_bib0012","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s40121-025-01170-x","article-title":"Clinical outcomes of eravacycline in patients treated for Stenotrophomonas maltophilia infections","volume":"14","author":"Al Musawa","year":"2025","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jgar.2026.04.013_bib0013","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2025"},{"key":"10.1016\/j.jgar.2026.04.013_bib0014","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 15.0, 2025. http:\/\/eucast.org [accessed 09.28.25]."},{"key":"10.1016\/j.jgar.2026.04.013_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01065-24","article-title":"Population pharmacokinetics and pulmonary modeling of eravacycline and the determination of microbiological breakpoint and cutoff of PK\/PD","volume":"69","author":"Ji","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.04.013_bib0016","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","year":"2024"},{"key":"10.1016\/j.jgar.2026.04.013_bib0017","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s11749-018-0611-5","article-title":"Mode testing, critical bandwidth and excess mass","volume":"28","author":"Jose Ameijeiras-Alonso","year":"2019","journal-title":"TEST"},{"key":"10.1016\/j.jgar.2026.04.013_bib0018","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2024"},{"key":"10.1016\/j.jgar.2026.04.013_bib0019","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/CMR.00117-14","article-title":"The challenge of efflux-mediated antibiotic resistance in gram-negative bacteria","volume":"28","author":"Li","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2026.04.013_bib0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fmicb.2015.00305","article-title":"Efflux pump-mediated drug resistance in Burkholderia","volume":"6","author":"Podnecky","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2026.04.013_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104986","article-title":"The contribution of antibiotic resistance mechanisms in clinical Burkholderia cepacia complex isolates: an emphasis on efflux pump activity","volume":"9","author":"Tseng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2026.04.013_bib0022","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00920-21","article-title":"Conservation of resistance-nodulation-cell division efflux pump-mediated antibiotic resistance in Burkholderia cepacia complex and Burkholderia pseudomallei complex species","volume":"65","author":"Somprasong","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.04.013_bib0023","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00049-18","article-title":"Substrate specificities and efflux efficiencies of RND efflux pumps of Acinetobacter baumannii","volume":"200","author":"Leus","year":"2018","journal-title":"J Bacteriol"},{"key":"10.1016\/j.jgar.2026.04.013_bib0024","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3390\/antibiotics10070863","article-title":"Role of RND efflux pumps in drug resistance of cystic fibrosis pathogens","volume":"10","author":"Scoffone","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jgar.2026.04.013_bib0025","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.diagmicrobio.2013.06.011","article-title":"Performance of MALDI-ToF MS for species identification of Burkholderia cepacia complex clinical isolates","volume":"77","author":"Fehlberg","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2026.04.013_bib0026","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00030-19","article-title":"Advances in the microbiology of Stenotrophomonas maltophilia","volume":"34","author":"Brooke","year":"2021","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2026.04.013_bib0027","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3389\/fmicb.2018.00549","article-title":"Frequency and genetic determinants of tigecycline resistance in clinically isolated Stenotrophomonas maltophilia in Beijing, China","volume":"9","author":"Zhao","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2026.04.013_bib0028","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01176-17","article-title":"Contribution of the TetB efflux pump to minocycline susceptibility among carbapenem-resistant Acinetobacter baumannii strains","volume":"61","author":"Wang","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.04.013_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1151594","article-title":"Genomic features, antimicrobial susceptibility, and epidemiological insights into Burkholderia cenocepacia clonal complex 31 isolates from bloodstream infections in India","volume":"13","author":"Saroha","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jgar.2026.04.013_bib0030","first-page":"29","article-title":"Molecular identification and tetracycline's resistance genes among Burkholderia cepacia isolates","volume":"56","author":"Shallin","year":"2023","journal-title":"Pakistan Heart Journal"},{"key":"10.1016\/j.jgar.2026.04.013_bib0031","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.1128\/AAC.03800-14","article-title":"Differential roles of RND efflux pumps in antimicrobial drug resistance of sessile and planktonic Burkholderia cenocepacia cells","volume":"58","author":"Buroni","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.04.013_bib0032","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3947\/ic.2024.0110","article-title":"Minocycline susceptibility of carbapenem-resistant Acinetobacter baumannii blood isolates from a single center in Korea: role of tetB in resistance","volume":"57","author":"Kim","year":"2025","journal-title":"Infect Chemother"},{"key":"10.1016\/j.jgar.2026.04.013_bib0033","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.2147\/IDR.S357344","article-title":"Minocycline susceptibility and tetB gene in carbapenem-resistant Acinetobacter baumannii in Taiwan","volume":"15","author":"Yang","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jgar.2026.04.013_bib0034","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jgar.2025.06.021","article-title":"Comparative in vitro activities of eravacycline and tigecycline against carbapenem-resistant Acinetobacter baumannii: insights from whole genome sequencing analysis","volume":"44","author":"Zhong","year":"2025","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jgar.2026.04.013_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117666","article-title":"Activity and resistance mechanisms of the third generation tetracyclines tigecycline, eravacycline and omadacycline against nationwide Spanish collections of carbapenemase-producing enterobacterales and Acinetobacter baumannii","volume":"181","author":"Garcia","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jgar.2026.04.013_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.584789","article-title":"AdeABC efflux pump controlled by AdeRS two component system conferring resistance to tigecycline, omadacycline and eravacycline in clinical carbapenem resistant Acinetobacter nosocomialis","volume":"11","author":"Lee","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2026.04.013_bib0037","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01332-21","article-title":"Activity of imipenem-relebactam against multidrug- and extensively drug-resistant Burkholderia cepacia complex and Burkholderia gladioli","volume":"65","author":"Becka","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2026.04.013_bib0038","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/antibiotics11050612","article-title":"Antibiotic therapy for difficult-to-treat infections in lung transplant recipients: a practical approach","volume":"11","author":"van den Bogaart","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jgar.2026.04.013_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.tpr.2024.100170","article-title":"Multi-target combination of antibiotics as salvage therapy for severe infection caused by pan-resistant Burkholderia cenocepacia following lung transplantation","volume":"10","author":"Cassir","year":"2025","journal-title":"Transplantation Reports"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526000639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526000639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:29:52Z","timestamp":1781767792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716526000639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":39,"alternative-id":["S2213716526000639"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2026.04.013","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative in vitro activity of minocycline, tigecycline, eravacycline, and omadacycline against Acinetobacter baumannii, Stenotrophomonas maltophilia, and the Burkholderia cepacia complex","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2026.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}